Vimarsana
Biggest News Aggregation in the World

Universal Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Universal Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Universal Diagnostics Today - Breaking & Trending Today

Cancer Prevention and Early Detection Are One Step Closer as Universal DX Announces Breakthrough Study Results From Its Multi-Omics + Computational Biology + ML Blood Test - Vimarsana News

Cancer Prevention and Early Detection Are One Step Closer as Universal DX Announces Breakthrough Study Results From Its Multi-Omics + Computational Biology + ML Blood Test

/PRNewswire/ -- Universal Diagnostics (UDX), a bioinformatics and multi-omics company on a mission to transform cancer into a curable disease, today announced...

Pandemic Boosts Diagnostics Field with High Revenues and Acquisitions - Vimarsana News

Pandemic Boosts Diagnostics Field with High Revenues and Acquisitions

Pandemic Boosts Diagnostics Field with High Revenues and Acquisitions 20/04/2021 - 5 minutes The US medtech firm Hologic has bought the Finnish-French biotech Mobidiag for around €668M in the latest of a series of mergers, acquisitions, and stock market launches taking over the diagnostics market. Hologic’s move is the latest in a flurry of activity from the women’s health specialist, which has snapped up Diagenode in Belgium, Biotheranostics in the US, and Somatex in Germany this year alone.  This is just one example of the many financial transactions happening in the diagnostics mark...

Universal Diagnostics Presents Promising Data on Lung Cancer Detection using Blood-Based Methylation Test at the IASLC 2020 World Conference on Lung Cancer - Vimarsana News

Universal Diagnostics Presents Promising Data on Lung Cancer Detection using Blood-Based Methylation Test at the IASLC 2020 World Conference on Lung Cancer

(0) Universal Diagnostics (UDX), an in-vitro diagnostics company developing minimally-invasive, blood-based solutions for detecting cancer early, announced today promising new data for its investigational blood-based lung cancer test. The data, presented at the IASLC 2020 World Conference on Lung Cancer hosted by the International Association for the Study of Lung Cancer (WCLC20), held virtually 28 th-31 st January 2021, used methylation status measurement of the tumour-derived portion from cell-free DNA (cfDNA) in plasma for patient classification. Results of the study show the potential...